Bristol Myers Squibb offers a 4.6% yield with an 85% payout ratio, while Medtronic has a 2.9% yield and is close to Dividend King status. Pfizer boasts a 6.8% yield, but with a payout ratio over 100%. Bristol Myers Squibb faces patent cliff risks, but its dividend is likely to survive.

Medtronic, though experiencing slower growth, is streamlining operations and investing in new products. The company’s dividend growth has been steady for 48 years, with potential for Dividend King status. Balance risk and reward with Bristol Myers Squibb and Medtronic for sustainable yields.

Read more at Yahoo Finance: Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever